Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22244
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2024 AND VI 85 AND IP 5
Results: 20
1
2
<sup>99m</sup>Tc‐labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra‐articular treatment of rheumatoid arthritis.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22247
- By:
- Publication type:
- Article
3
Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro‐inflammatory cytokines and oxidative stress.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22246
- By:
- Publication type:
- Article
4
Kynurenine pathway in type 2 diabetes: Role of metformin.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22243
- By:
- Publication type:
- Article
5
Targeted degradation of KRAS protein in non‐small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and pharmacokinetic profiles.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22241
- By:
- Publication type:
- Article
6
Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra‐1 signaling pathway by reducing DKK3.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22222
- By:
- Publication type:
- Article
7
RETRACTION: "Dose‐dependent Chemopreventive Effects of Citronellol in DMBA‐Induced Breast Cancer Among Rats".
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22238
- Publication type:
- Article
8
Design of novel broad‐spectrum antiviral nucleoside analogues using natural bases ring‐opening strategy.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22237
- By:
- Publication type:
- Article
9
A novel cinnamic and caffeic acid‐conjugated peptide analogs with anticonvulsant and analgesic potency: Comparative analyses of trans/cis isomers.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22236
- By:
- Publication type:
- Article
10
Enriching iPSC research diversity: Harnessing human biobank collections for improved ethnic representation.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22227
- By:
- Publication type:
- Article
11
Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine‐containing hydrazone derivatives as cholinesterase inhibitors.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22240
- By:
- Publication type:
- Article
12
Discovery of 5‐(1‐benzyl‐1H‐imidazol‐4‐yl)‐1,2,4‐oxadiazole derivatives as novel RIPK1 inhibitors via structure‐based virtual screening.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22235
- By:
- Publication type:
- Article
13
Recombinant human epidermal growth factor‐loaded liposomes and transferosomes for dermal delivery: Development, characterization, and cytotoxicity evaluation.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22234
- By:
- Publication type:
- Article
14
Antiplasmodial action of 4‐nitrobenzenesulfonamide chalcones: Design, synthesis, characterisation, in vitro and in silico evaluation against blood stages of Plasmodium falciparum 3D7.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22233
- By:
- Publication type:
- Article
15
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22232
- By:
- Publication type:
- Article
16
Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22231
- By:
- Publication type:
- Article
17
Inhibition of the TCF12/VSIG4 axis by palbociclib diminishes the proliferation and migration of glioma cells and decreases the M2 polarization of glioma‐associated microglia.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22230
- By:
- Publication type:
- Article
18
Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin‐2‐one derivatives.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22229
- By:
- Publication type:
- Article
19
Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22228
- By:
- Publication type:
- Article
20
Issue Information.
- Published in:
- Drug Development Research, 2024, v. 85, n. 5, p. 1, doi. 10.1002/ddr.22226
- Publication type:
- Article